tapcom ophthalmic solution
santen pharma malaysia sdn. bhd. - tafluprost; timolol maleate -
taflotan-s ophthalmic solution 0.0015% (single-dose container)
santen pharma malaysia sdn. bhd. - tafluprost -
iluvien 190 micrograms intravitreal implant in applicator
alimera sciences europe limited, - fluocinolone acetonide - intravitreal implant in applicator - 190 microgram(s) - fluocinolone acetonide
tasigna 200 mg
novartis israel ltd - nilotinib as monohydrate - capsules - nilotinib as monohydrate 200 mg - nilotinib - nilotinib - treatment of philadelphia chromosome positive chronic myeloid leukaemia (ph+ cml) in chronic or accelerated phase in patients resistant to or experiencing significant toxicity during treatment with imatinib.treatment of adult patients with newly diagnosed philadelphia chromosome positive chronic myelogenous leukemia in chronic phase.
tasigna 150 mg
novartis israel ltd - nilotinib as hydrochloride monohydrate - capsules - nilotinib as hydrochloride monohydrate 150 mg - nilotinib - nilotinib - treatment of adult patients with newly diagnosed philadelphia chromosome positive chronic myelogenous leukemia in chronic phase.
iluvien
alimera sciences limited - fluocinolone acetonide - 190 microgram - fluocinolone acetonide
iluvien 190microgram intravitreal implant in applicator
alimera sciences ltd - fluocinolone acetonide - prolonged-release intravitreal implant - 190microgram
beovu 120 mgml
novartis israel ltd - brolucizumab - solution for injection - brolucizumab 120 mg / 1 ml - brolucizumab - beovu is indicated in adults for the treatment of neovascular (wet) age-related macular degeneration (amd).
cytarabine 20 mg/ml solution for injection/infusion
accord healthcare limited - cytarabine - solution for injection/infusion - 20 milligram(s)/millilitre - pyrimidine analogues; cytarabine
rasagiline 1mg tablets
dr reddy's laboratories (uk - rasagiline - tablet - 1mg